1. Home
  2. OSW vs AGIO Comparison

OSW vs AGIO Comparison

Compare OSW & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpaWorld Holdings Limited

OSW

OneSpaWorld Holdings Limited

HOLD

Current Price

$24.20

Market Cap

2.4B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.28

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSW
AGIO
Founded
2017
2007
Country
Bahamas
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
OSW
AGIO
Price
$24.20
$28.28
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$27.00
$38.88
AVG Volume (30 Days)
707.2K
856.8K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$961,001,000.00
$43,011,000.00
Revenue This Year
$7.49
$76.75
Revenue Next Year
$8.52
$170.73
P/E Ratio
$114.24
N/A
Revenue Growth
7.37
N/A
52 Week Low
$18.19
$22.24
52 Week High
$25.75
$46.00

Technical Indicators

Market Signals
Indicator
OSW
AGIO
Relative Strength Index (RSI) 52.02 48.36
Support Level $23.12 $26.42
Resistance Level $25.50 $29.37
Average True Range (ATR) 0.76 0.95
MACD -0.04 0.16
Stochastic Oscillator 46.94 63.67

Price Performance

Historical Comparison
OSW
AGIO

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: